[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361574-105":59,"doc-detail-361574-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-tumor-immune-microenvironment-of-thyroid-cancer-and-colorectal-cancer-cellular-crosstalk-and-therapeutic-implications","The tumor immune microenvironment of thyroid cancer and colorectal cancer: cellular crosstalk and therapeutic implications","","Thyroid cancer and colorectal cancer impose significant global disease burden, and the tumor immune microenvironment (TIME) governs tumor initiation, progression, immune escape, and treatment response. Cellular composition and intercellular communication networks differ markedly between these malignancies, yet shared immune-suppression mechanisms drive resistance. Single-cell sequencing and spatial transcriptomics expose heterogeneous immune and stromal states, cytokine networks, and metabolic programs. This mini review compares TIME features and cellular crosstalk to inform biomarker-guided immunotherapy and rational combination strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-tumor-immune-microenvironment-of-thyroid-cancer-and-colorectal-cancer-cellular-crosstalk-and-therapeutic-implications/361574/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-tumor-immune-microenvironment-of-thyroid-cancer-and-colorectal-cancer-cellular-crosstalk-and-therapeutic-implications/361574.png","ImageObject",300,407,{"name":92,"@type":93},"moss~","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does the tumor immune microenvironment (TIME) regulate in thyroid cancer and colorectal cancer?","Question",{"text":112,"@type":113},"TIME regulates tumor progression, immune escape, and therapeutic response by involving tumor cells, immune cells, stromal cells, and extracellular matrix components.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do thyroid cancer and colorectal cancer differ in immune-cell and biomarker features?",{"text":117,"@type":113},"Thyroid cancer is often characterized by an immunosuppressive phenotype with enriched TAMs and Tregs, while aggressive subtypes show high PD-L1. CRC immune architecture is strongly linked to microsatellite status, with MSI-H tumors showing more tumor-infiltrating lymphocytes and better response to PD-1/PD-L1 blockade.",{"name":119,"@type":110,"acceptedAnswer":120},"Which shared mechanisms contribute to immune suppression across both cancer types?",{"text":121,"@type":113},"Both cancers share immune-suppressive mediator production by TAMs and Tregs (e.g., IL-10 and TGF-β) and cooperation with inhibitory immune checkpoint pathways, alongside cytokine/chemokine networks and metabolic competition.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361574,1790307698,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","TYPE Mini Review  \nPUBLISHED 04 September 2026 DOI 10.3389/fimmu.2026.1916192  \nOPEN ACCESS  \nEDITED BY  \nYunfei Liu,  \nCentral South University, China  \nREVIEWED BY  \nDi Du,  \nExxonMobil Research and Engineering, United States  \nPeng Wang,  \nArmy Medical University, China  \n*CORRESPONDENCE  \nChengzhong Xing  \n[xcz1966@126.com](xcz1966@126.com)[ ](xcz1966@126.com)Yuehua Gong  \n[yhgong@cmu.edu.cn](yhgong@cmu.edu.cn)[ ](yhgong@cmu.edu.cn)RECEIVED 22 June 2026 REVISED 21 August 2026 ACCEPTED 21 August 2026 PUBLISHED 04 September 2026  \nCITATION  \nZhang G, Xing C and Gong Y (2026) The tumor immune microenvironment of thyroid cancer and colorectal cancer: cellular crosstalk and therapeutic implications.  \nFront. Immunol. 17:1916192 .  \ndoi: 10.3389/fimmu.2026.1916192  \nCOPYRIGHT  \n© 2026 Zhang, Xing and Gong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe tumor immune microenvironment of thyroid cancer and colorectal cancer: cellular crosstalk and therapeutic implications  \nGuangzhe Zhang 1, Chengzhong Xing 2* and Yuehua Gong 3*  \n1 Department of Thyroid Surgery, First Hospital of China Medical University, Shenyang, Liaoning, China, 2 Department of Anus and Intestine Surgery, First Afﬁliated Hospital of China Medical University, Shenyang, Liaoning, China, 3Tumor Etiology and Screening Department of Cancer Institute and General Surgery, The First Hospital of China Medical University, Shenyang, China  \nThyroid cancer (TC) and colorectal cancer are common malignancies of the endocrine and gastrointestinal systems, respectively, and continue to impose a substantial global disease burden. The tumor immune microenvironment (TIME) plays a central role in tumor initiation, progression, and therapeutic response; however, the cellular composition and intercellular communication networks within the TIME exhibit marked heterogeneity between these two malignancies. Recent advances in single-cell sequencing and spatial transcriptomics have revealed complex and dynamic alterations in immune cell subsets, stromal cell functions, cytokine networks, and metabolic programs within the TIME. In particular, bidirectional communication between tumor cells and immune cells has emerged as a critical determinant of immune evasion and therapeutic resistance. Nevertheless, most existing studies have focused on individual tumor types, and systematic comparisons of the shared and distinct features of the TIME in thyroid cancer and colorectal cancer remain limited. Moreover, combination therapeutic strategies targeting the TIME are still under active investigation. This review systematically compares the immune microenvironments of thyroid cancer (TC) and colorectal cancer (CRC), highlighting the development of more precise and effective immunotherapeutic strategies for thyroid cancer and colorectal cancer.  \nKEYWORDS  \ncellular crosstalk, colorectal cancer, immunotherapy, single-cell sequencing, thyroid cancer, tumor immune microenvironment  \n1 Introduction  \nThe tumor immune microenvironment, comprising tumor cells, immune cells, stromal cells, and extracellular matrix components, critically regulates tumor progression, immune escape, and therapeutic response. In thyroid cancer, the TIME is generally characterized by an immunosuppressive phenotype with enrichment of tumor-associated macrophages (TAMs) and regulatory T cells (Tregs), particularly in aggressive subtypes such as anaplastic  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nthyroid carcinoma (ATC) (1) . Distinct histological subtypes, including papillary, follicular, and anaplastic","cbCaiu68VsgtHesD","https://ap.wps.com/l/cbCaiu68VsgtHesD","pdf",1017058,"English","# Introduction\n## Tumor immune microenvironment in thyroid cancer and colorectal cancer\n### Diversity and functional r","[{\"question\":\"What does the tumor immune microenvironment (TIME) regulate in thyroid cancer and colorectal cancer?\",\"answer\":\"TIME regulates tumor progression, immune escape, and therapeutic response by involving tumor cells, immune cells, stromal cells, and extracellular matrix components.\"},{\"question\":\"How do thyroid cancer and colorectal cancer differ in immune-cell and biomarker features?\",\"answer\":\"Thyroid cancer is often characterized by an immunosuppressive phenotype with enriched TAMs and Tregs, while aggressive subtypes show high PD-L1. CRC immune architecture is strongly linked to microsatellite status, with MSI-H tumors showing more tumor-infiltrating lymphocytes and better response to PD-1/PD-L1 blockade.\"},{\"question\":\"Which shared mechanisms contribute to immune suppression across both cancer types?\",\"answer\":\"Both cancers share immune-suppressive mediator production by TAMs and Tregs (e.g., IL-10 and TGF-β) and cooperation with inhibitory immune checkpoint pathways, alongside cytokine/chemokine networks and metabolic competition.\"}]","The tumor immune microenvironment of thyroid cancer and colorectal cancer: cellular crosstalk and therapeutic implications | PDF",1790144892,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e5c03ecbcbb03a1a6c074f670c112c2b.webp",983,1389,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eaee8339988693f1a2d4f6e8fd56ea9d.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5700d975e25975d148c5fc802fe8f5a7.webp",981,1386,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/22523a43355e1a8a3457d2f8bbccfa2c.webp",980,1385]